Thomson Health head steps down

Share this article:
Kevin King, president and CEO of Thomson Healthcare, has left the company. It remains unclear whether he will be replaced, company officials said.

King left the firm towards the end of June. He arrived in March of 2005 from GE Medical Systems Information Technologies and GE Global Clinical Systems. His responsibilities are being absorbed by Bob Cullen, president and CEO of Thomson Scientific and Healthcare.

Thomson announced last month that it would divest its medical education business, which pulled in $97 million in revenue for 2005, accounting for about one tenth of the scientific and healthcare group's total revenues.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in News

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...